Clinical Trials Directory

Trials / Completed

CompletedNCT02843698

Effects of Dexmedetomidine on Oxygenation and Lung Mechanics in Morbidly Obese Patients Undergoing Bariatric Operations

Effects of Dexmedetomidine on Oxygenation and Lung Mechanics in Morbidly Obese Patients Undergoing Bariatric Operations: A Randomized Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
42 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The study aims to investigate the effect of dexmedetomidine on oxygenation and lung mechanics in morbidly obese patients

Detailed description

The patients of interest are morbid obese patients scheduled for bariatric surgery. Dexmeditomidine will be infused intraoperatively after induction of anesthesia. lung mechanics (dead space and compliance) as well as oxygenation (PF ratio) will be monitored intraoperatively and postoperatively

Conditions

Interventions

TypeNameDescription
DRUGDexmedetomidineDexmedetomidine infusion was previously reported to improve oxygenation and lung dynamics in patients with obstructive lung diseases. In our study we are going to investigate its effect on oxygenation and lung dynamics in restrictive lung disease
DRUGNormal salineNormal saline

Timeline

Start date
2016-09-01
Primary completion
2017-08-26
Completion
2017-08-26
First posted
2016-07-26
Last updated
2017-08-29

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02843698. Inclusion in this directory is not an endorsement.